Question 1

What is Moyamoya disease?

Accepted Answer

Moyamoya disease is a rare intracranial arteriopathy characterized by progressive narrowing of the arteries at the base of the brain. This vascular condition can lead to reduced blood flow, resulting in transient ischemic attacks or strokes. While the precise biological mechanisms remain under investigation, research has implicated variants in genes such as ANO1, ACTA2, and GUCY1A1 that are believed to influence vascular function. The disease is rare, affecting roughly 1 to 9 people per million, and can present in both children and adults.

Question 2

What are the symptoms of Moyamoya disease?

Accepted Answer

Individuals with Moyamoya disease often experience symptoms related to reduced cerebral blood flow. The clinical presentation may include transient episodes of neurological dysfunction, such as weakness, speech difficulties, or vision problems, which can signal transient ischemic attacks or strokes. Not all individuals experience all features, and severity varies considerably. Because the condition affects blood flow to the brain, symptoms can evolve over time and may require careful monitoring.

Question 3

What causes Moyamoya disease?

Accepted Answer

Research has implicated several genes in Moyamoya disease, including ANO1, ACTA2, and GUCY1A1, which play roles in vascular smooth muscle function and the regulation of blood flow. Disruptions in the functions of these genes may contribute to the progressive narrowing of the cerebral arteries. The precise genetic causes and inheritance patterns of Moyamoya disease remain unclear, with many cases appearing to occur sporadically. Families considering genetic testing may benefit from a consultation with a genetic counselor for further evaluation. Associated genes include ANO1, ACTA2, GUCY1A1.

Question 4

How rare is Moyamoya disease?

Accepted Answer

Moyamoya disease is classified as rare. The estimated prevalence is approximately 1-9 in 1,000,000. Because rare disease data can be limited, actual numbers may differ from published estimates.

Question 5

How is Moyamoya disease diagnosed?

Accepted Answer

The diagnosis of Moyamoya disease typically relies on a comprehensive clinical evaluation, including imaging studies such as angiography that reveal characteristic narrowing of the intracranial vessels. Although molecular genetic testing can be used to identify pathogenic variants in genes like ANO1, ACTA2, and GUCY1A1, the diagnosis is primarily made based on clinical and radiographic findings. Because symptoms can overlap with other cerebrovascular conditions, a combination of detailed clinical history and imaging is essential to confirm the diagnosis.

Question 6

Are there treatments for Moyamoya disease?

Accepted Answer

Currently, management of Moyamoya disease focuses on supportive care and symptom management, as there are no treatments that have been approved specifically for this condition. Management strategies generally involve a multidisciplinary approach, which may include surgical revascularization procedures to improve blood flow along with ongoing neurological care. Patients are typically managed through individualized treatment plans that address symptoms and reduce the risk of stroke while emphasizing the importance of regular follow-up. It is recommended that patients discuss treatment options and potential interventions with their healthcare team, including genetic counseling for further guidance.

Question 7

Are there clinical trials for Moyamoya disease?

Accepted Answer

Yes, there are currently 26 active clinical trials for Moyamoya disease registered on ClinicalTrials.gov. Clinical trials test new treatments, procedures, or approaches. Your healthcare provider can help determine if a trial might be appropriate for your situation. Visit the Treatment section of this page for more details.

Question 8

What complications can arise from Moyamoya disease?

Accepted Answer

Complications from Moyamoya disease can include recurrent transient ischemic attacks or strokes due to reduced blood flow to the brain. These events can lead to lasting neurological issues, such as weakness, speech difficulties, or vision problems. It's important for individuals with Moyamoya disease to have regular follow-ups to monitor their condition and manage any complications.

Question 9

How does Moyamoya disease affect daily life?

Accepted Answer

Living with Moyamoya disease can impact daily life in various ways, especially due to symptoms like weakness or speech difficulties. Individuals may need to adjust their activities and seek support for tasks that require concentration or physical effort. Regular medical care and a supportive network can help manage these challenges and improve quality of life.

Question 10

What is the prognosis for someone with Moyamoya disease?

Accepted Answer

The prognosis for Moyamoya disease varies widely among individuals. Some may experience recurrent neurological events, while others can maintain a stable condition for many years. Factors like age at diagnosis and access to specialized care can influence outcomes, so it's essential to work closely with healthcare providers for the best management.

Question 11

Should families consider genetic counseling for Moyamoya disease?

Accepted Answer

Yes, families considering Moyamoya disease may benefit from genetic counseling. This can help them understand the potential genetic factors involved and the implications for family planning. A genetic counselor can provide valuable information about testing options and the inheritance patterns associated with the disease.

Research Type	Count	% of Total
Research summaries	94	21%
Disease patterns and progression	74	17%
Patient case studies	73	16%
Laboratory research	71	16%
Clinical study results	61	14%
Testing and diagnosis research	51	12%
New treatment approaches	11	2%
Other research	8	2%

Kisho

Moyamoya disease

Overview

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

Recent Publications

Latest News & Developments

Differences in Intracranial Artery and Brain Impairment Between Pediatric and Adult Moyamoya Disease: A Comparative MRI Study.

Fregoli syndrome in an adolescent with Moyamoya disease.

Lipid metabolism in moyamoya disease: Emerging evidence, vascular remodeling, and therapeutic implications.

Moyamoya disease

Overview

Diagnosis

Prognosis

Research Landscape

Medical References

External Resources

Orphanet

GARD

Subtypes

Related Diseases

Questions for Your Care Team

Questions for Your Care Team

FAQ

Frequently Asked Questions

What is Moyamoya disease?

What are the symptoms of Moyamoya disease?

What causes Moyamoya disease?

How rare is Moyamoya disease?

How is Moyamoya disease diagnosed?

Are there treatments for Moyamoya disease?

Are there clinical trials for Moyamoya disease?

What complications can arise from Moyamoya disease?

How does Moyamoya disease affect daily life?

What is the prognosis for someone with Moyamoya disease?

Should families consider genetic counseling for Moyamoya disease?

Recent Publications

Latest News & Developments

Differences in Intracranial Artery and Brain Impairment Between Pediatric and Adult Moyamoya Disease: A Comparative MRI Study.

Fregoli syndrome in an adolescent with Moyamoya disease.

Lipid metabolism in moyamoya disease: Emerging evidence, vascular remodeling, and therapeutic implications.